Elseginy S
J Comput Aided Mol Des. 2024; 38(1):16.
PMID: 38556596
PMC: 10982093.
DOI: 10.1007/s10822-024-00553-5.
Hassan M, Shahzadi S, Yasir M, Chun W, Kloczkowski A
Sci Rep. 2023; 13(1):18022.
PMID: 37865690
PMC: 10590448.
DOI: 10.1038/s41598-023-45347-1.
Shah M, Woo H
Front Mol Biosci. 2023; 10:1236617.
PMID: 37828918
PMC: 10565033.
DOI: 10.3389/fmolb.2023.1236617.
Aloufi B, Alshammari A, Alshammari N, Alam M
Bioinformation. 2023; 18(7):622-629.
PMID: 37313055
PMC: 10259223.
DOI: 10.6026/97320630018622.
Shah M, Shin J, Woo H
Front Immunol. 2023; 14:1113175.
PMID: 37063859
PMC: 10102385.
DOI: 10.3389/fimmu.2023.1113175.
Antibacterial activity of a novel compound isolated from Bacillus licheniformis for treating bacterial infections in fishes: An in-silico approach.
Mondal H, Silvia D, Arnold Emerson I, Chandrasekaran N, Mukherjee A, Thomas J
Mol Cell Biochem. 2023; 478(12):2609-2620.
PMID: 36894690
DOI: 10.1007/s11010-023-04687-2.
Co-evolution-based prediction of metal-binding sites in proteomes by machine learning.
Cheng Y, Wang H, Xu H, Liu Y, Ma B, Chen X
Nat Chem Biol. 2023; 19(5):548-555.
PMID: 36593274
DOI: 10.1038/s41589-022-01223-z.
molecular modelling, MM/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-]quinolines as potential anti-tumor agents.
Dasmahapatra U, Kumar C, Das S, Subramanian P, Murali P, Isaac A
Front Chem. 2022; 10:991369.
PMID: 36247684
PMC: 9566731.
DOI: 10.3389/fchem.2022.991369.
Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking.
Elseginy S, Oliveira A, Shoemark D, Sessions R
RSC Med Chem. 2022; 13(8):929-943.
PMID: 36092142
PMC: 9384815.
DOI: 10.1039/d1md00392e.
Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach.
Singh S, Banavath H, Godara P, Naik B, Srivastava V, Prusty D
3 Biotech. 2022; 12(9):198.
PMID: 35923684
PMC: 9342843.
DOI: 10.1007/s13205-022-03258-4.
Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.
Hassan M, Yasir M, Shahzadi S, Kloczkowski A
ACS Omega. 2022; 7(23):19243-19260.
PMID: 35721972
PMC: 9202290.
DOI: 10.1021/acsomega.2c00518.
NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine/Acylcarnitine Carrier.
Zhang N, Jia X, Fan S, Wu B, Wang S, Ouyang B
Int J Mol Sci. 2022; 23(9).
PMID: 35563000
PMC: 9103206.
DOI: 10.3390/ijms23094608.
Structural mechanism of DNA-mediated Nanog-Sox2 cooperative interaction.
Yesudhas D, Anwar M, Choi S
RSC Adv. 2022; 9(14):8121-8130.
PMID: 35521171
PMC: 9061787.
DOI: 10.1039/c8ra10085c.
SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses.
Shah M, Moon S, Kim J, Thao T, Woo H
Comput Struct Biotechnol J. 2022; 20:2042-2056.
PMID: 35495107
PMC: 9040525.
DOI: 10.1016/j.csbj.2022.04.030.
analysis of SARS-CoV-2 papain-like protease potential inhibitors.
Elseginy S, Anwar M
RSC Adv. 2022; 11(61):38616-38631.
PMID: 35493238
PMC: 9044241.
DOI: 10.1039/d1ra07845c.
Molecular docking and simulation of IcaC protein as O-succinyltransferase function in biofilm formation.
Prabu R, Mohanty A, Balakrishnan S, Jayalakshmi G, Sundar K
Curr Res Struct Biol. 2022; 4:78-86.
PMID: 35399651
PMC: 8987812.
DOI: 10.1016/j.crstbi.2022.03.002.
-Acetyldopamine dimers from attenuates lipopolysaccharides induced inflammation and inhibits cathepsin C activity.
Bahuguna A, Khaket T, Bajpai V, Shukla S, Park I, Na M
Comput Struct Biotechnol J. 2022; 20:1177-1188.
PMID: 35317232
PMC: 8908036.
DOI: 10.1016/j.csbj.2022.02.011.
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
Shah M, Woo H
Front Immunol. 2022; 12:830527.
PMID: 35140714
PMC: 8819067.
DOI: 10.3389/fimmu.2021.830527.
Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold.
Elseginy S, Anwar M
ACS Omega. 2022; 7(1):1150-1164.
PMID: 35036778
PMC: 8756603.
DOI: 10.1021/acsomega.1c05732.
Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic analysis.
Hassan M, Zahid S, Alashwal H, Kloczkowski A, Moustafa A
Sci Rep. 2021; 11(1):12256.
PMID: 34112868
PMC: 8192743.
DOI: 10.1038/s41598-021-91606-4.